Health Logistics
FedEx has obtained 30 IATA CEIV Pharma certifications at its air and cargo hubs worldwide, positioning itself as a key provider in the transport of critical pharmaceutical products. This milestone reinforces its capability in managing temperature-sensitive shipments for the healthcare sector.
The transport and logistics company FedEx Corp. (NYSE: FDX) has reached a strategic milestone in its healthcare logistics division by achieving a total of 30 certifications IATA CEIV Pharma in its main air hubs and cargo handling facilities on a global scale. This achievement positions FedEx among the leading suppliers in the sector, with one of the most extensive networks recognized for its excellence in the management and transport of pharmaceutical products.
This recognition, issued by the Asociación de Transporte Aéreo Internacional (IATAThis underscores the multinational's commitment to precision and quality in the healthcare supply chain. Furthermore, it highlights the capabilities of its division. FedEx Life Sciences for the transport of critical and temperature-sensitive shipments, a key factor for the success of the pharmaceutical and biotechnology industry.
A guarantee of quality for the global cold chain
CEIV Pharma certification is a global standard that ensures facilities, equipment, and personnel meet the highest requirements for handling pharmaceutical products. This includes manufacturer regulations, airline regulations, and international standards.
Brendan Sullivan, global cargo director of IATA, has positively assessed this development: "The pharmaceutical industry depends on air transport to ensure that time-sensitive and temperature-controlled medicines and therapies reach the doctors and patients who need them." Sullivan He added: "We are pleased to see how FedEx "It obtains this renowned seal of quality and excellence in the handling of pharmaceutical products, while continuing to expand its global network."
From FedExThis achievement is seen as another step in a long-term strategy to dominate the healthcare logistics segment. Nick Gennari, President of FedEx Healthcare and Life SciencesHe stated: “We are proud to reach this important milestone, but our work does not end here. This achievement represents a new step on our path to building one of the most advanced healthcare logistics networks in the world.” The executive concluded by affirming that “quality will continue to be a central element of the expansion of FedEx Life Sciences and we look forward to continuing to collaborate closely with IATA».
| Concept | Detail |
|---|---|
| Certification Obtained | IATA CEIV Pharma |
| Number of Certifications | 30 facilities worldwide |
| Responsible Division | FedEx Life Sciences |
| Annual Income (FedEx Corp.) | 86.000 million |
With annual revenues of $86.000 billion and more than 450.000 employees, FedEx Corp. It positions itself as a key player in global trade. The company maintains its strategic objective of achieving carbon-neutral operations by 2040, a commitment that also encompasses its growing operations in the healthcare sector.
Frequently Asked Questions (FAQ)
What is IATA CEIV Pharma certification?
It is a seal of quality and excellence awarded by the International Air Transport Association (IATA) which certifies that a company's facilities and processes meet the highest standards for handling and transporting pharmaceutical products, especially those that are sensitive to temperature and time.
How many certifications of this type has FedEx obtained?
FedEx has achieved a total of 30 certifications IATA CEIV Pharma at its air hubs and cargo facilities distributed around the world.
What does this achievement mean for the healthcare sector?
It strengthens the global supply chain for medicines and therapies, ensuring that products reach doctors and patients safely and effectively. For pharmaceutical companies, having a logistics partner with this certification minimizes risks in the transport of high-value and critically sensitive goods.
Continuous newsroom for Empresa Exterior. A team specializing in real-time monitoring and writing up-to-the-minute daily news on international markets, ensuring constant updates on B2B developments.